• [1]  于卉. “人体结构与功能Ⅱ”课程思政教学探究.  教育教学论坛,  150-153, 2023. 
• [2]  姜威. GABA transporter 1 is a promising drug target for CUL4B mutation-associated epilepsy.  ACTA PHARMACOLOGICA SINICA,  2025. 
• [3]  曹志远. Sublethal executioner caspase activation in hepatocytes promotes liver regeneration through the JAK/STAT3 pathway.  PLOS BIOLOGY,  23,  2025. 
• [4]  刘海亭. lncRNA THAP7-AS1, transcriptionally activated by SP1 and post-transcriptionally stabilized by METTL3-mediated m6A modification, exerts oncogenic properties by improving CUL4B entry into the nucleus.  Cell Death and Differentiation,  29,  627-641, 2022. 
• [5]  刘凯旋. CUL4B protects kidneys from acute injury by restraining p53/PAI-1 signaling.  Cell Death & Disease,  15,  2024. 
• [6]  于瑞祺. Cullin 4B-RING E3 ligase negatively regulates the immunosuppressive capacity of mesenchymal stem cells by suppressing iNOS.  Cell Death and Differentiation,  2024. 
• [7]  马燕燕. CUL4B mutations impair human cortical neurogenesis through PP2A-dependent inhibition of AKT and ERK.  Cell Death & Disease,  15,  2024. 
• [8]  姜威. The X-linked intellectual disability gene CUL4B is critical for memory and synaptic function.  Acta Neuropathologica Communications,  2024. 
• [9]  张树永. 化学支持“四新建设”的进展、思路与重点.  大学化学,  1-7, 2022. 
• [10]  柳晓晨. CUL4B functions as a tumor suppressor in KRAS-driven lung tumors by inhibiting the recruitment of myeloid-derived suppressor cells.  Oncogene,  2023.